Treatment and dose escalation scheme. #Vinorelbine dose escalation.... | Download Scientific Diagram
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival - The Lancet Oncology
Addition of cetuximab to chemotherapy shortens OS in advanced colorectal cancer subset
Frontiers | Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60
REACH treatment schedule: Cetuximab (Erbitux®) is given at a loading... | Download Scientific Diagram
Taking ERBITUX | HCP | ERBITUX (cetuximab)
Frontiers | PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab
Erbitux
Erbitux® (cetuximab)
Locoregional Head & Neck Cancer | HCP | ERBITUX (cetuximab)
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience - ScienceDirect
ERBITUX (cetuximab) for Head and Neck Cancer and Colorectal Cancer - Cancer Therapy Advisor
Overview of selected cetuximab q2w dosing studies in which KRAS... | Download Table
Cetuximab Carboplatin Fluorouracil Protocol V1.0 | PDF | Renal Function | Dose (Biochemistry)
Approved for use in:
Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
Dose-response curves of cetuximab in NPC cell lines. Cells were... | Download Scientific Diagram
Involvement of face T-zone after two doses of cetuximab therapy... | Download Scientific Diagram
JCI Insight - First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients
Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer | Research To Practice
Overview of selected cetuximab q2w dosing studies in which KRAS... | Download Table
Comparison Between Biweekly and Weekly Cetuximab in Patients With Metastatic Colorectal Cancer: A Meta-analysis | Anticancer Research
